跳轉至內容
Merck
  • The Ca(v)3.1 T-type calcium channel is required for neointimal formation in response to vascular injury in mice.

The Ca(v)3.1 T-type calcium channel is required for neointimal formation in response to vascular injury in mice.

Cardiovascular research (2012-08-14)
Bing-Hsiean Tzeng, Yen-Hui Chen, Ching-Hui Huang, Shin-Shiou Lin, Kuan-Rong Lee, Chien-Chang Chen
摘要

Restenosis is an undesirable consequence following percutaneous vascular interventions. However, the current strategy for preventing restenosis is inadequate. The aim of this study was to investigate the role of low-voltage gated T-type calcium channels in regulating vascular smooth muscle cell (VSMC) proliferation during neointimal formation. Wire injury of mice carotid arteries resulted in neointimal formation in the wild-type and Ca(v)3.2(-/-) but not Ca(v)3.1(-/-) mice, indicating a critical role of Ca(v)3.1 in neointimal formation. In addition, we found a significant increase of Ca(v)3.1 mRNA and protein in injured arteries. Ca(v)3.1 knockout or knockdown (shCa(v)3.1) reduced VSMC proliferation. Since T-channels are expressed predominantly in the G(1) and S phases in VSMCs, we examined whether an abnormal G(1)/S transition was the cause of the reduced cell proliferation in shCa(v)3.1 VSMCs. We found a disrupted expression of cyclin E in shCa(v)3.1 VSMCs, and calmodulin agonist CALP1 partially rescued the defective cell proliferation. Furthermore, we demonstrated that infusion of NNC55-0396, a selective T-channel blocker, inhibited neointimal formation in wild-type mice. Ca(v)3.1 is required for VSMC proliferation during neointimal formation, and blocking of Ca(v)3.1 may be beneficial for preventing restenosis.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
嘌呤霉素 二盐酸盐 来源于白色链球菌, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
抗肌动蛋白,α-平滑肌抗体,小鼠单克隆, clone 1A4, purified from hybridoma cell culture